EASTONBIOPHARMACEUTICALS(SH:688513) Xin Lang Cai Jing·2025-09-25 03:43Core Viewpoint - Yuan Dong Bio's stock price has shown significant volatility, with a year-to-date increase of 100.73%, but a recent decline over the past 20 days of 7.55% [1] Group 1: Stock Performance - As of September 25, Yuan Dong Bio's stock price was 59.63 CNY per share, with a market capitalization of 10.527 billion CNY [1] - The stock experienced a 2.00% decline during the trading session, with a trading volume of 91.3911 million CNY and a turnover rate of 0.86% [1] - Year-to-date, the stock has increased by 100.73%, with a 0.74% increase over the last five trading days and a 40.14% increase over the last 60 days [1] Group 2: Financial Performance - For the first half of 2025, Yuan Dong Bio reported revenue of 654 million CNY, a year-on-year decrease of 2.25%, and a net profit attributable to shareholders of 137 million CNY, down 6.77% year-on-year [2] - The company has distributed a total of 341 million CNY in dividends since its A-share listing, with 212 million CNY distributed over the past three years [3] Group 3: Shareholder Information - As of June 30, the number of shareholders for Yuan Dong Bio was 5,462, a decrease of 22.97% from the previous period [2] - The average number of circulating shares per shareholder increased by 29.82% to 32,320 shares [2] Group 4: Company Overview - Yuan Dong Bio, established on June 1, 2009, is located in Chengdu, Sichuan Province, and was listed on September 2, 2020 [1] - The company's main business includes the research, production, and sales of chemical raw materials and chemical drug formulations, with 78.75% of revenue from formulation sales [1]